Vildan GÖRGÜLÜ, Fazila ATAKAN ERKAL, Şenay TUĞLU ATAMAN, Esra ÇİFTÇİ, Önder SER, Elçin YENİDÜNYA KONUK, Fırat KÖSE

RT-PCR ile pozitif saptanan COVID-19 vakalarının değerlendirilmesi

Amaç: Bu çalışmada Antalya Halk Sağlığı Laboratuvarı (AHSL)’na COVID-19 şüphesi ile gönderilen örneklerin RT-PCR ile incelenmesi ve vakaların epidemiyolojik ve klinik özelliklerinin araştırılması amaçlanmıştır. Yöntem: Bu çalışma, 18 Mart 2020 ile 18 Mayıs 2020 tarihleri arasında AHSL’na COVID-19 şüphesi ile gelen 6404 solunum yolu örneği üzerinde yapıldı. Solunum yolu örneklerinde Real Time PCR testi ile SARS CoV-2 spesifik N ve Orf1ab gen bölgeleri analiz edildi. Test yapılan kişilerin tıbbi, epidemiyolojik ve demografik bilgilerine retrospektif olarak ulaşıldı. Gruplar arası oransal farklılıkları karşılaştırmak için ki-kare testi kullanıldı. Bulgular: 6.404 solunum yolu örneğinin %6,2’si (n=398) pozitif saptandı. Testin yapıldığı ay ile PCR pozitiflik oranı arasında anlamlı farklılık görüldü (p

Evaluation of COVID-19 cases detected positive by RT-PCR

Objective: In this study, it was aimed to examine samples sent to Antalya Public Health Laboratory (AHSL) with the suspicion of COVID-19 by RT-PCR and to investigate the epidemiological and clinical characteristics of the cases. Methods: This study, conducted between 18 March 2020 and 18 May 2020, retrospectively analyzed on 6404 respiratory tract samples that came to AHSL with suspected COVID-19. SARS CoV-2 specific N and Orf1ab gene regions were analyzed with Real Time PCR test in respiratory tract samples. Medical, epidemiological and demographic information of the people who were tested were obtained retrospectively. Chi-square test was used to compare the proportional differences between groups. Results: In this study 6.2% (n = 398) of 6,404 respiratory tract samples were found to be positive. There was a significant difference between the month of the test and the PCR positivity rate (p

PDF

___

1. Sijia T, Nan H, Jing L, Kun C, Xuqin K, Zhenjun X et al. Characteristics of COVID-19 infection in Beijing. J Infect, 2020; 80(4): 401–406.
2. Nanshan C, Min Z, Xuan D, Jieming Q, Fengyun G, Yang H, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020; 395(10223): 507–513.
3. Huilan T, Sheng T, Shiqi G, Anwen S, Jifang S. The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event. J Infect, 2020; 81(1): 1-9.
4. Chih-Cheng L, Tzu-Ping S, Wen-Chien K, Hung-Jen T, Po-Ren H. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents, 2020; 55(3): 105924.
5. Rui L, Huan H, Fang L, Zhihua L, Kailang W, Yingle L, et al. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin Chim Acta, 2020; 505: 172-175.
6. Qun L, Xuhua G, Peng W, Xiaoye W, Lei Z, Yeqing T et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med, 2020; 382(13): 1199–1207.
7. Jingchun F, Xiaodong L, Guojun S, Junpin Q, Yi L, Weimin P, et al. The epidemiology of reverse transmission of COVID-19 in Gansu Province, China. Travel Med Infect Dis, 2020; 37: 101741.
8. Chen W, Peter WH, Frederick GH, George FG. A novel coronavirus outbreak of global health concern. Lancet, 2020; 395(10223): 470–473.
9. Haneen A, Ghina’a I Abu D, Alaa A A A, Kamal D, Murtaza M T. COVID-19 pandemic: an overview of epidemiology, parthenogenesis, diagnostics and potential vaccines and therapeutics. Ther Deliv, 2020; 11(4): 245-268.
10. MOH, TurkeyScientific Advisory Board. COVID-19 (SARS-CoV-2 Infection) General Information, Epidemiology and Diagnosis. Turkey: Ministry of Health, General Directorate of Public Health; 27 November 2020.
11. Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat Protoc, 2006; 1(3): 1559–1582.
12. Görgülü Ö , Duyan M. rRT-PCR Results of a Covid-19 Diagnosed Geriatric Patient. SN Compr Clin Med, 2020; 2(11): 2423-2426.
13. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect, 2020; 104(3): 246–251.
14. Zhoukun L, Xi X, Qingxin G, Lieguang Z, Liangping L, Xiaoping T, et al. Asymptomatic SARS-CoV-2 infected patients with persistent negative CT findings. Eur J Radiol, 2020; 126:108956.
15. Ma Y, Xu QN, Wang FL, Ma XM, Wang XY, Zhang XG. Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China. Microb Infect, 2020; 22: 212–217.
16. Görgülü Ö, Duyan M. Effects of comorbid factors on prognosis of three different geriatric groups with COVID-19 diagnosis. SN Compr Clin Med, 2020; 2(12): 2583-2594.
17. Karageçili H, Yıldırım Z. Epidemiological and clinical aspects of the COVID-19 pandemic and world common experiences in treatment: Turkey experience. Turk Hij Den Biyol Derg, 2020; 77(3): 355-366.
18. Michael L, Andrea M, Vincent M. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol, 2020; 5(4): 562-569.
19. Rinkoo D, Stefan RB, Ali El-A, Roman NR, Alexander M, Ben W, et al. The ACE-2 in COVID-19: Foe or Friend? Horm Metab Res, 2020; 52(5): 257-263.
20. Giuseppe P, Alessandro S, Chiara P, Federica B, Romualdo Del B, Fabio C, et al. COVID 19 diagnosis and management: a comprehensive review. J Intern Med, 2020; 288(2): 192-206.
21. Chadia H, Sandrella Bou M, Hala S, Pascale S. Smoking and COVID-19: A Scoping Review. Tob Use Insights, 2021; 14: 1179173X21994612.
22. Usman MS, Siddiqi TJ, Khan MS, Patel UK, Shahid I, Ahmed J, et al. Is there a smoker’s paradox in COVID-19? BMJ Evid Based Med, 2020;26(6):279-84.
23. Chaolin H, Yeming W, Xingwang L, Lili R, Jianping Z, Yi H, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020; 395(10223): 497-506.
24. Di W, Tiantian W, Qun L, Zhicong Y. The SARS-CoV-2 outbreak: What we know. Int J Infect Dis, 2020; 94: 44-48.